ArticleMicrobial cell factories2025
A standardized set of pNX vectors for enhanced soluble expression of recombinant proteins in E. coli using small fusion tags.
Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cis-Acting Chaperoning by Macromolecular Tethering: A Built-In Layer of Cellular Chaperoning.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe production of recombinant proteins in Escherichia coli (E. coli) is often hampered by the formation of inclusion bodies. While fusion tags can enhance solubility, existing systems are hampered by a lack of standardization, with tags scattered across disparate plasmid backbones and inconsistent cloning sites, complicating parallel screening.
resultsTo address this, we constructed a standardized series of expression vectors, termed pNX, by incorporating nine small fusion tags (SUMO, LD, ACP, BCCP, GB1, Fh8, SmbP, TolA, and TrxA) into a uniform pET-28b backbone. Each pNX vector features an identical configuration: a T7 promoter, an N-terminal fusion tag, a synthetic linker, a TEV protease cleavage site, and a multiple cloning site (MCS) flanked by dual 6×His tags. We evaluated this system using four model proteins (EcFabG, eGFP, XccXanA2, and XccXanL). Our results showed that specific tags significantly improved both the expression level and solubility of the target proteins without compromising their biological activity. Notably, the lipoyl domain (LD) was identified, to our knowledge for the first time, as an effective solubility enhancer. The standardized MCS enabled rapid, parallel cloning, facilitating the efficient screening of optimal fusion partners.
conclusionsThe pNX vector series provides a versatile and efficient platform for enhancing the soluble expression of challenging recombinant proteins in E. coli, streamlining the empirical identification of ideal fusion tags.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.